Royalty Pharma reports second quarter 2026 results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. ULS
8. AWK
9. DRI
10. USO

Go back to Royalty Pharma reports second quarter 2026 results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.21 -0.08 (0.14%)
Previous Close $58.29    52 Week High $3.48 
Open $58.50    52 Week Low $0.80 
Day High $58.50    P/E N/A 
Day Low $57.68    EPS $-1.54 
Volume 1,869,505